Pharmaceuticals
European regulator cracks down on drugs tested in India
25 Jul 2016
Generic drugs manufactured by the likes of Novartis AG, Teva Pharmaceutical, Mylan, and smaller Indian firms and tested at Indian sites are affected by the European Medicine Agency's strictures, which found 'substantial manipulation' of test results
AstraZeneca's bid to save Crestor sales fails, court turns down IPR protection request till 2026
21 Jul 2016
AstraZeneca’s last-ditch attempt to protect its statin Crestor failed as a federal judge denied its bid for a restraining order against Indian generic drugmakers

